期刊文献+

临床药师对1例妊娠甲状腺功能亢进患者的药学监护

Pharmaceutical Care for a Patient with Pregnancy Thyrotoxicosis by Clinical Pharmacists
原文传递
导出
摘要 目的:为妊娠甲状腺功能亢进患者用药提供参考。方法:临床药师通过参与妊娠甲状腺功能亢进患者治疗用药方案的制订,建议将富马酸比索洛尔片2.5 mg、qd、po,丙硫氧嘧啶50 mg、tid、po改为甲巯咪唑10 mg、qd、po,普萘洛尔10 mg、tid、po。结果:医师部分接受了药师的建议,改为甲巯咪唑10 mg、qd、po。2周后复查甲状腺功能较前改善,继续用药4周后甲状腺功能示血清游离三碘甲腺原氨酸(FT3)6.12 pmol/L、血清游离甲状腺素(FT4)22.61 pmol/L、促甲状腺激素(TSH)2.26μIU/ml,停用比索洛尔,甲巯咪唑改为5 mg、qd、po。继续用药1月后复查甲状腺功能FT3 5.5 pmol/L、FT4 20.97 pmol/L、TSH 2.63μIU/ml,停用甲巯咪唑。此后保持每4周定期复查甲状腺功能,均维持在正常范围,未再出现怕热多汗等症状,后自然分娩一健康女婴。结论:临床药师可通过规范的对症治疗改善妇女妊娠及胎儿的结局。 OBJECTIVE: To provide reference for drug use in patients with pregnancy thyrotoxicosis. METHODS: Clinical pharmacists participated in the formulation of drug therapy plan for patients with pregnancy thyrotoxicosis, and suggested that me- thidathion (10 mg, qd, po) and propranolol (10 mg, tid, po) to replac Bisoprolol fumarate tablet (2.5 mg, qd, po) and propyl- thiouracil (50 mg, tid, po). RESULTS: Physicians accepted some suggestions of clinical pharmacists, i.e. methidathion (10 mg, qd, po). The function of thyroid had been improved after 2 weeks of treatment. 4 weeks later, the function of thyroid was re- checked: FT3 6.12 pmol/L, FT4 22.61 pmol/L and TSH 2.26 μIU/ml. Bisoprolol therapy was discontinued, and the doses of methi- dathion changed into 5 mg, qd, po; 1 month later, the function of thyroid was rechecked: FT3 5.5 pmol/L, FT4 20.97 pmol/L and TSH 2.63 μIU/ml. Methidathion therapy was discontinued; the function of thyroid was rechecked every 4 weeks and kept in normal range; the symptoms as heat intolerance and sweating didn't occur again. The patient gave birth to a healthy baby girl naturally. CONCLUSIONS: Standard symptomatic treatment by clinical pharmacists can improve pregnancy outcome of woman and fetus.
出处 《中国药房》 CAS CSCD 2014年第30期2872-2874,共3页 China Pharmacy
关键词 妊娠甲状腺功能亢进 甲巯咪唑 丙硫氧嘧啶 患者教育 临床药师 Pregnancy thyrotoxicosis Methimazole Propylthiouracil Patient education Clinical pharmacist
  • 相关文献

参考文献6

二级参考文献157

  • 1连小兰,白耀,徐蕴华,戴为信,郭芝生.妊娠合并甲状腺功能亢进症患者抗甲状腺药物治疗后对其新生儿先天畸形的影响[J].中华妇产科杂志,2005,40(8):511-515. 被引量:43
  • 2卢德梅.妊娠合并甲状腺机能亢进的观察与护理[J].中国实用护理杂志(中旬版),2006,22(6):40-41. 被引量:4
  • 3单忠艳,滕卫平.甲状腺疾病与妊娠[J].国际内分泌代谢杂志,2006,26(5):295-302. 被引量:104
  • 4张京莉.妊娠合并甲状腺功能亢进24例临床观察[J].中国民康医学,2007,19(10):343-343. 被引量:5
  • 5陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011.81.
  • 6施秉银,马秀萍.现代甲状腺疾病诊断与治疗[M].西安:陕西科学技术出版社,1988:25-28.
  • 7Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med, 1989,321 : 13-16.
  • 8Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med, 1999,341:549-555.
  • 9Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2007,92 ( 8 Suppl) : S1-$47.
  • 10Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid diseases during pregnancy and postpartum. Thyroid, 2011,21 : 1081-1125.

共引文献1479

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部